Directed Evolution of AAV Capsid for Targeted Cancer Therapy

被引：0
|
作者：
Marsic, Damien [1 ]
Lu, Yuan [2 ]
Cao, Chunxia [3 ]
Phelan, Dane [1 ]
Govindasamy, Lakshmanan [4 ]
Kaye, Frederic J. [3 ]
Agbandje-McKenna, Mavis [4 ]
Ghivizzani, Steve [2 ]
Zolotukhin, Sergei [1 ]
机构：
[1] Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Orthopaed & Rehabil, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Med, Div Hematol & Oncol, Gainesville, FL USA
[4] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
335
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [41] Immune Response to AAV Vector Capsid and Assessment of Eligibility for AAV Mediated Gene Therapy for Duchenne Muscular Dystrophy
    Saha, Madhurima
    MOLECULAR THERAPY, 2022, 30 (04) : 76 - 76
  • [42] Novel AAV capsid variant for efficient and effective inner ear gene therapy
    Rossi, A.
    Marx, J.
    Huang, P.
    Warnecke, A.
    Schambach, A.
    Stacker, H.
    Buening, H.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A31 - A31
  • [43] The Biochemical and Functional Effects of Spontaneous Deamidation of the AAV Capsid on Gene Therapy Vectors
    Giles, April R.
    Alvira, Mauricio R.
    Lock, Martin
    Wilson, James M.
    MOLECULAR THERAPY, 2014, 22 : S85 - S85
  • [44] T cell responses to AAV vector capsid limit the duration of transgene expression in humans after liver-directed gene therapy.
    Mingozzi, F
    Maus, MV
    Sabatino, DE
    Hui, D
    Manno, CS
    Ragni, MV
    High, KA
    BLOOD, 2005, 106 (11) : 855A - 855A
  • [45] Towards A DNA-Directed RNA Interference (ddRNAi) Therapy Delivered Intravitreally Using a Novel AAV Capsid to Treat Choroidal Neovascularization (CNV)
    Suhy, David
    Kao, Shih-chu
    Kotterman, Melissa Ann
    Doan, Albert
    Ufombah-Strings, Vanessa
    Kloth, Claudia
    Suhy, Natalie
    Roelvink, Peter
    Kirn, David
    Schaffer, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [46] Evolution of androgen receptor targeted therapy for advanced prostate cancer
    Wong, Yien Ning Sophia
    Ferraldeschi, Roberta
    Attard, Gerhardt
    de Bono, Johann
    NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (06) : 365 - 376
  • [47] Evolution of androgen receptor targeted therapy for advanced prostate cancer
    Yien Ning Sophia Wong
    Roberta Ferraldeschi
    Gerhardt Attard
    Johann de Bono
    Nature Reviews Clinical Oncology, 2014, 11 : 365 - 376
  • [48] Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
    Jadvar, Hossein
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (02) : 277 - 288
  • [49] BIOACTIVITY-DIRECTED DRUG SCREENING AND PROSTATE CANCER: TOWARDS TARGETED THERAPY
    Roubin, R. H.
    Meng, Q.
    Hanrahan, J. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 29 - 29
  • [50] Structure-guided AAV capsid evolution strategies for enhanced CNS gene delivery
    Gonzalez, Trevor J.
    Mitchell-Dick, Aaron
    Blondel, Leo O.
    Fanous, Marco M.
    Hull, Joshua A.
    Oh, Daniel K.
    Moller-Tank, Sven
    Rivera, Ruth M. Castellanos
    Piedrahita, Jorge A.
    Asokan, Aravind
    NATURE PROTOCOLS, 2023, 18 (11) : 3413 - +
12345